- Home
- TNGX vs ISPR Comparison
TNGX vs ISPR Comparison
Compare TNGX & ISPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNGX
- ISPR
- Stock Information
- Founded
- TNGX 2014
- ISPR 2019
- Country
- TNGX United States
- ISPR United States
- Employees
- TNGX N/A
- ISPR 98
- Industry
- TNGX Biotechnology: Pharmaceutical Preparations
- ISPR Medicinal Chemicals and Botanical Products
- Sector
- TNGX Health Care
- ISPR Health Care
- Exchange
- TNGX Nasdaq
- ISPR Nasdaq
- Market Cap
- TNGX 413.6M
- ISPR 324.6M
- IPO Year
- TNGX N/A
- ISPR 2023
- Fundamental
- Price
- TNGX $3.04
- ISPR $5.73
- Analyst Decision
- TNGX Strong Buy
- ISPR Strong Buy
- Analyst Count
- TNGX 8
- ISPR 1
- Target Price
- TNGX $13.14
- ISPR $12.50
- AVG Volume (30 Days)
- TNGX 1.5M
- ISPR 74.1K
- Earning Date
- TNGX 11-06-2024
- ISPR 02-18-2025
- Dividend Yield
- TNGX N/A
- ISPR N/A
- EPS Growth
- TNGX N/A
- ISPR N/A
- EPS
- TNGX N/A
- ISPR N/A
- Revenue
- TNGX $43,383,000.00
- ISPR $148,382,357.00
- Revenue This Year
- TNGX $27.73
- ISPR $23.73
- Revenue Next Year
- TNGX N/A
- ISPR $75.56
- P/E Ratio
- TNGX N/A
- ISPR N/A
- Revenue Growth
- TNGX 15.67
- ISPR 12.82
- 52 Week Low
- TNGX $2.70
- ISPR $5.01
- 52 Week High
- TNGX $13.01
- ISPR $13.04
- Technical
- Relative Strength Index (RSI)
- TNGX 39.30
- ISPR 45.22
- Support Level
- TNGX $2.72
- ISPR $5.30
- Resistance Level
- TNGX $3.29
- ISPR $6.13
- Average True Range (ATR)
- TNGX 0.30
- ISPR 0.36
- MACD
- TNGX 0.07
- ISPR -0.01
- Stochastic Oscillator
- TNGX 32.08
- ISPR 39.81
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. Its program TNG908, is an MTA-cooperative inhibitor of PRMT5 designed to work selectively in cancer cells with an MTAP deletion. Its pipeline further consists of discovery programs such as, TNG462, TNG348, TNG260 and others for multiple cancer types with limited treatment options.
About ISPR Ispire Technology Inc.
Ispire Technology Inc is engaged in the research and development, design, commercialization, sales, marketing, and distribution of branded e-cigarettes and cannabis vaping products. The company sells its cannabis vaping in the United States, Europe, Canada, and South Africa.